• English
    • About GAfPA
    • Regions
      • Overview
      • Asia
      • Australia
      • Europe
      • Latin America
    • Resources
      • Europe
      • Latin America
      • International
      • Blog
    • Events
    • Contact

    Biologics prices prompt WHO call for affordable biosimilars

    June 6, 2014

    By GAfPA

    More at BioPharma Reporter

    « Ensure Patient Safety When Naming Biological Medications
    WHO Calls for Improved, Science-based Regulations on Biosimilars »

    About

    GAfPA’s insight on news, research and educational resources for patient advocates the world over.

    Subscribe

    Sign up with your email address to receive news and updates.

    Categories

    • Asia
    • Australia
    • Biologics
    • Europe
    • Events
    • GAfPA Infographics & White Papers
    • GAfPA Videos
    • Latin America
    • News
    • Oncology
    • Pain
    • Trainings & Workshops
    • Uncategorized
    • WHO Updates

    Recent Posts

    • New “Fast Facts” Highlights Impact of High Cholesterol on Europe
    • England Sets Sights on Heart Health
    • GAfPA’s Statement Supporting the USMCA Signing at the G20 Summit
    • GAfPA Statement on United States-Mexico-Canada Agreement
    • La farmacovigilancia como modo de reforzamiento de regulaciones

    Not on our email list?

    Subscribe

    Global Alliance for Patient Access

    info@gafpa.org
    T: +1 (202) 499-4114

    Home
    About
    Regions
    Asia
    Australia
    Europe
    Latin America
    Resources
    Blog
    Events
    Contact

    © 2019 GAfPA. All Rights Reserved. | Design by Conflare

    Educate. Advocate. Access.